Molecular imaging using PET for breast cancer.

Item

http://www.wikidata.org/entity/Q38444869

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Molecular imaging using PET for breast cancer.

@en

type

Item

label

Molecular imaging using PET for breast cancer.

@en

prefLabel

Molecular imaging using PET for breast cancer.

@en

P1476

Molecular imaging using PET for breast cancer.

@en

P2093

Akinobu Hamada

http://www.w3.org/2001/XMLSchema#string

Chikako Shimizu

http://www.w3.org/2001/XMLSchema#string

Harukaze Yamamoto

http://www.w3.org/2001/XMLSchema#string

Hiroaki Kurihara

http://www.w3.org/2001/XMLSchema#string

Hitomi Tani

http://www.w3.org/2001/XMLSchema#string

Jun Hashimoto

http://www.w3.org/2001/XMLSchema#string

Kan Yonemori

http://www.w3.org/2001/XMLSchema#string

Kenji Tamura

http://www.w3.org/2001/XMLSchema#string

Makoto Kodaira

http://www.w3.org/2001/XMLSchema#string

Masayuki Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography

Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

MRI of tumor angiogenesis.

Assessing the future of diffuse optical imaging technologies for breast cancer management

Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.

Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.

P2888

s12282-015-0613-z

P304

24-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12282-015-0613-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275587223

http://www.w3.org/2001/XMLSchema#string

P6179

1032992084

http://www.w3.org/2001/XMLSchema#string

P698

25917108

http://www.w3.org/2001/XMLSchema#string